Role of recombinant human granulocyte colony-stimulating factor in development of cancer-associated venous thromboembolism in lung cancer patients who undergo chemotherapy

BackgroundThe role of recombinant human granulocyte colony-stimulating factor (rhG-CSF), especially the long-acting factor in the development of cancer-associated venous thromboembolism (VTE) in lung cancer patients who undergo chemotherapy has been understudied, although the use of rhG-CSF has been...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Yi Cheng, Yunfeng Zhao, Mei Xu, He Du, Jinyuan Sun, Qihuan Yao, Jianmin Qu, Song Liu, Xuejun Guo, Wei Xiong
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2024-05-01
Sarja:	Frontiers in Immunology
Aiheet:	venous thromboembolism chemotherapy granulocyte colony-stimulating factor lung cancer rhG-CSF
Linkit:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1386071/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!